Caribou Biosciences, Inc. Increase (Decrease) in Other Receivables
Caribou Biosciences, Inc. (CRBU) reported Increase (Decrease) in Other Receivables of -$769.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherReceivables · last filed 2026-08-13
- Caribou Biosciences, Inc. increase (decrease) in other receivables for the quarter ending 2026-06-30 was -$310.00K, a 376.79% decline year-over-year.
- Caribou Biosciences, Inc. increase (decrease) in other receivables for the quarter ending 2026-03-31 was -$459.00K, a 2800.00% decline year-over-year.
- Caribou Biosciences, Inc. increase (decrease) in other receivables for the quarter ending 2025-12-31 was $76.00K, a 47.59% decline year-over-year.
- Caribou Biosciences, Inc. increase (decrease) in other receivables for the quarter ending 2025-09-30 was -$129.00K.
- Caribou Biosciences, Inc. increase (decrease) in other receivables for fiscal 2025 was $76.00K.
- Caribou Biosciences, Inc. increase (decrease) in other receivables for fiscal 2024 was -$458.00K, a 745.07% decline from fiscal 2023.
- Caribou Biosciences, Inc. increase (decrease) in other receivables for fiscal 2023 was $71.00K.
- Caribou Biosciences, Inc. increase (decrease) in other receivables for fiscal 2022 was -$3.27M, a 281.56% decline from fiscal 2021.
| Period end | Increase (Decrease) in Other Receivables 3 month | Increase (Decrease) in Other Receivables 6 month | Increase (Decrease) in Other Receivables 9 month | Increase (Decrease) in Other Receivables 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$310.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$769.00K 10-Q · filed 2026-08-13 | -$693.00K derived: sum of 3 quarters · filed 2026-08-13 | -$822.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$459.00K 10-Q · filed 2026-05-07 | -$383.00K derived: sum of 2 quarters · filed 2026-05-07 | -$512.00K derived: sum of 3 quarters · filed 2026-05-07 | -$400.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $76.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$53.00K derived: sum of 2 quarters · filed 2026-03-05 | $59.00K derived: sum of 3 quarters · filed 2026-08-13 | $76.00K 10-K · filed 2026-03-05 |
| 2025-09-30 | -$129.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$17.00K derived: sum of 2 quarters · filed 2026-08-13 | $0.00 10-Q · filed 2025-11-12 | $145.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $112.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $129.00K 10-Q · filed 2026-08-13 | $274.00K derived: sum of 3 quarters · filed 2026-08-13 | $228.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $17.00K 10-Q · filed 2026-05-07 | $162.00K derived: sum of 2 quarters · filed 2026-05-07 | $116.00K derived: sum of 3 quarters · filed 2026-05-07 | $120.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $145.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $99.00K derived: sum of 2 quarters · filed 2026-03-05 | $103.00K derived: sum of 3 quarters · filed 2026-03-05 | -$458.00K 10-K · filed 2026-03-05 |
| 2024-09-30 | -$46.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$42.00K derived: sum of 2 quarters · filed 2025-11-12 | -$603.00K 10-Q · filed 2025-11-12 | -$662.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$557.00K 10-Q · filed 2025-08-12 | -$616.00K derived: sum of 3 quarters · filed 2025-08-12 | $234.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | -$561.00K 10-Q · filed 2025-05-08 | -$620.00K derived: sum of 2 quarters · filed 2025-05-08 | $230.00K derived: sum of 3 quarters · filed 2025-05-08 | $55.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $791.00K derived: sum of 2 quarters · filed 2025-03-10 | $616.00K derived: sum of 3 quarters · filed 2025-03-10 | $71.00K 10-K · filed 2025-03-10 |
| 2023-09-30 | $850.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $675.00K derived: sum of 2 quarters · filed 2024-11-06 | $130.00K 10-Q · filed 2024-11-06 | -$355.00K derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | -$175.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$720.00K 10-Q · filed 2024-08-06 | -$1.21M derived: sum of 3 quarters · filed 2024-08-06 | -$1.60M derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | -$545.00K 10-Q · filed 2024-05-07 | -$1.03M derived: sum of 2 quarters · filed 2024-05-07 | -$1.43M derived: sum of 3 quarters · filed 2024-05-07 | -$2.50M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | -$485.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | -$880.00K derived: sum of 2 quarters · filed 2024-03-11 | -$1.96M derived: sum of 3 quarters · filed 2024-03-11 | -$3.27M 10-K · filed 2024-03-11 |
| 2022-09-30 | -$395.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$1.47M derived: sum of 2 quarters · filed 2023-11-07 | -$2.78M 10-Q · filed 2023-11-07 | -$2.66M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -$1.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$2.39M 10-Q · filed 2023-08-08 | -$2.26M derived: sum of 3 quarters · filed 2023-08-08 | -$4.48M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | -$1.31M 10-Q · filed 2023-05-09 | -$1.19M derived: sum of 2 quarters · filed 2023-05-09 | -$3.41M derived: sum of 3 quarters · filed 2023-05-09 | -$608.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $127.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | -$2.09M derived: sum of 2 quarters · filed 2023-03-09 | $705.00K derived: sum of 3 quarters · filed 2023-03-09 | $1.80M 10-K · filed 2023-03-09 |
| 2021-09-30 | -$2.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $578.00K derived: sum of 2 quarters · filed 2022-11-08 | $1.67M 10-Q · filed 2022-11-08 | $2.36M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $2.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $3.89M 10-Q · filed 2022-08-09 | $4.58M derived: sum of 3 quarters · filed 2022-08-09 | $4.96M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $1.09M 10-Q · filed 2022-05-09 | $1.78M derived: sum of 2 quarters · filed 2022-05-09 | $2.16M derived: sum of 3 quarters · filed 2022-05-09 | |
| 2020-12-31 | $687.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | $1.07M derived: sum of 2 quarters · filed 2022-03-21 | $540.00K 10-K · filed 2022-03-21 | |
| 2020-09-30 | $380.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$147.00K 10-Q · filed 2021-11-09 | ||
| 2020-06-30 | -$527.00K 10-Q · filed 2021-09-02 | |||
| 2019-12-31 | $870.00K 10-K · filed 2022-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |